Two patients walk into a clinic... a genomics perspective on the future of schizophrenia

AP Corvin - BMC biology, 2011 - Springer
Progress is being made in schizophrenia genomics, suggesting that this complex brain
disorder involves rare, moderate to high-risk mutations and the cumulative impact of small …

Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia

S Papiol, D Malzahn, A Kästner, S Sperling… - Translational …, 2011 - nature.com
Genotype–phenotype correlations of common monogenic diseases revealed that the degree
of deviation of mutant genes from wild-type structure and function often predicts disease …

[PDF][PDF] A szkizofrénia diagnózisa Bleulertől a DSM-V-ig

R JÁNOS - Neuropsychopharmacol Hung, 2011 - mppt.hu
A szkizofrénia diagnózisa lényeges változásokon ment keresztül a betegség első leírásai
óra, a rendszer alakulása a jelenlegi diagnosztikai revíziók idején is folyamatban van. A …

From Bleuler to DSM-V: Diagnosing schizophrenia

R János - Neuropsychopharmacologia Hungarica, 2011 - elibrary.ru
The diagnosis of schizophrenia has undergone substantial change during the last 100 years
since its first descriptions by Kraepelin and Bleuler, this process is still continuing at present …

[HTML][HTML] Overlap of genetic influences in phenotypes classically categorized as psychiatric vs medical disorders

RC McEachin, JD Cavalcoli - World Journal of Medical Genetics, 2011 - wjgnet.com
Psychiatric disorders have traditionally been segregated from medical disorders in terms of
drugs, treatment, insurance coverage and training of clinicians. This segregation is …